Publications Database

Curran L. K. et al. (2007)

Behaviors associated with fever in children with autism spectrum disorders.

Behavioural Brain Research

(120), e1386-1392

Read Abstract (New Window)

D'Urso G. et al. (2014)

Transcranial direct current stimulation for autistic disorder.

Biological Psychiatry

September, 1(76), e5-6.

Read Abstract (New Window)

David , Geier D. A. , Geier M. R. (2006)

The biochemical basis and treatment of autism: interactions between mercury, transsulfuration, and androgens.

Autoimmunity Reviews

Read Full (New Window)

DiMartino A. et al. (2004)

Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.

Journal of Child and Adolescent Psychopharmacology

14(2), pp. 207-218

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Dialogues in Clinical Neuroscience

14(3), pp. 263-279.

Read Abstract (New Window) Read Full (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Eaves L. C. , Ho H. H. , Eaves D. M. (1994)

Subtypes of autism by cluster analysis.

Journal of Autism and Developmental Disorders

24(1), pp. 3-22

Read Abstract (New Window)

Edelson S. E. (1990)

The candida yeast-autism connection

San Diego, CA: Autism Research Institute

ElChaar G. M. et al. (2004)

Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.

Mental Retardation and Developmental Disabilities Research Reviews

10(3), pp. 193-200.

Read Abstract (New Window)

Epp K. M. (1993)

Outcome-based evaluation of a social skills program using art therapy and group therapy for children on the autism spectrum.

Children and Schools

30(1), pp. 27-36

Read Abstract (New Window)

Eppright T. , Sanfacon J. , Horwitz E. (1996)

Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship.

Missouri Medicine

93(3), pp. 136-138.

Read Abstract (New Window)

Erickson C. A. et al. (2014)

Brief report: Pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder.

Journal of Autism and Developmental Disorders

April, 44(4), pp. 981-987.

Read Abstract (New Window)

Erickson C. A. et al. (2013)

Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.

Psychopharmacology (Berl)

July, 228(1), pp. 75-78.

Read Abstract (New Window)

Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)

Open-label memantine in fragile X syndrome.

Journal of Autism and Developmental Disorders

39(12), pp. 1629-1635.

Read Abstract (New Window)

Escalona A. et al. (2001)

Brief report: improvements in the behavior of children with autism following massage therapy.

Journal of Autism and Developmental Disorders

31(5), pp. 513-516.

Read Abstract (New Window)

Fatemi S. H. (1998)

Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial

Journal of Autism and Developmental Disorders

28(4), pp. 303-307

Read Abstract (New Window)

Fayyazi A. et al. (2014)

A comparison of risperidone and buspirone for treatment of behavior disorders in children with phenylketonuria.

Iranian Journal of Child Neurology

Fall, 8(4), pp. 33-38.

Read Abstract (New Window) Read Full (New Window)

Feingold Association of the United States (2008)

Overview [of the Feingold Diet].

Riverhead, NY: Feingold Association of the United States

Feingold Association of the United States (2008)

Symptoms that may be helped by the Feingold Program.

Riverhead, NY: Feingold Association of the United States

Fernández-Jaén A. et al. (2013)

Efficacy of atomoxetine for the treatment of ADHD symptoms in patients with pervasive developmental disorders: A prospective, open-label study.

Journal of Attention Disorders

17(6), pp. 497-505.

Read Abstract (New Window)